leadf
logo-loader
viewPsyence Group Inc
(
CSE:PSYG
)

Psyence Group 'delighted' to reach psilocybin product development agreement with Jamaican government

Psyence Group Inc (CSE:PSYG)'s Jody Aufrichtig tells Proactive the Toronto-based group struck a multi-year collaboration agreement with the Jamaican government’s Scientific Research Council that sets the stage for psilocybin product development.

Aufrichtig says the collaboration will consist of three main initiatives: developing psilocybin-based nutraceuticals; identifying and collecting Jamaica’s psychedelic and psychoactive mushrooms, and sorting protocols to optimize spawn production of rare psychedelic mushroom species for up to three years.

Quick facts: Psyence Group Inc

Follow
CSE:PSYG

Price: 0.2 CAD

Market Cap: $17.11 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

Psyence Group launches its functional mushroom products under the GOODMIND...

Psyence Group Inc (CSE:PSYG) (CSE:PSYG)'s Tony Budden caught up with Proactive New York to discuss the the international biotechnology company with operations in South Africa's launch of its range of functional mushroom products under the GOODMIND banner. Budden says the GOODMIND formula...

on 23/8/21

2 min read